Browse Tag

Molecular Fragments (OPMF)

Fujitsu Leverages World's Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City

University of Tokyo’s RCAST, Fujitsu, and Kowa Successfully Create Promising New Compounds to Fight Drug-Resistant Cancer

The University of Tokyo’s Research Center for Advanced Science and Technology (RCAST), Fujitsu Limited, and Kowa Company Ltd. today announced that using IT-based drug discovery technologies, which entails computer-based virtual design and

June 13, 2018

News

Go toTop

Molecular Fragments (OPMF)

University of Tokyo’s RCAST, Fujitsu, and Kowa Successfully Create Promising New Compounds to Fight Drug-Resistant Cancer

About

Categories

Social Links